Blackstone invests $400m in HK-listed HEC Pharma via convertible bonds

By
Posted

The drugmaker, based in China’s Hubei province, is planning to use the funds to acquire drugs and other pharma products

Blackstone holds talks to pick stake in Jet Airways loyalty arm

By

The private equity firm has expressed interest in a deal that could value Jet Privilege Pvt at about $429 million.


Southeast Asia is filled with mediocre performance: Brahmal Vasudevan, Creador

By

It won’t be easy for newcomers to participate in the Southeast Asia deal landscape, he said.


TPG, Northstar consortium sells 19.9% stake in Indonesia’s BFI Finance

By

The buyer is Italian consumer credit service provider Compass Banca, a subsidiary of Italian investment bank Mediobanca.


CPPIB may acquire $277m debt renewable power firm Mytrah raised from Piramal

By

Talks with CPPIB follow the delisting of Mytrah’s holding company from the London Alternative Investment Market (AIM) in May.


China’s sovereign wealth fund backs $13b takeover of Yum China

By

The investor group considering a takeover bid for Yum China includes DCP Capital and Hillhouse.


Macquarie Capital’s Green Investment Group acquires solar assets from Conergy Asia

By

This acquisition is seen to complement GIG’s expertise in wind, waste-from-energy and disruptive green energy technologies.


India Digest: Carlyle may back BDR Pharma; PE funds eye Esskay; Bain in race for Max Healthcare

By

Bain is looking to buy the stake from South Africa’s Life Healthcare in a deal valued between $450-$540 million.


India Digest: Jet Airways plans $400m stake sale; Blackstone may sell Pune assets to Xander

By

The airline is also trying to monetise the frequent flyer programme it co-owns with partner Etihad Airways.


Global PE firm KKR betting on Chinese millennials

By

After making a trip to China, KKR wrote about the rise of Asian millenials, particularly the ones in China.